Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial - Aix-Marseille Université Access content directly
Journal Articles Lancet Oncology Year : 2015

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Jean-Yves Blay
Isabelle Ray-Coquard
Thibaud Valentin
  • Function : Author
Antoine Italiano

Domains

Cancer
No file

Dates and versions

hal-03623747 , version 1 (29-03-2022)

Identifiers

Cite

Axel Le Cesne, Jean-Yves Blay, Julien Domont, Emmanuelle Tresch-Bruneel, Christine Chevreau, et al.. Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial. Lancet Oncology, 2015, 16 (3), pp.312-319. ⟨10.1016/s1470-2045(15)70031-8⟩. ⟨hal-03623747⟩
24 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More